Desired event can be experienced more than once in many studies, for each person. Such outcomes have been named as recurrent events. Such data occur mostly in longitudinal follow-up research. Example for recurrent events include bladder tumor relapse times among patients in a and recurrent heart attacks (
1,
2). In other words, recurrent event data are mostly faced with clinical and observational studies regarding biomedical science. The effect of two kinds of recurrences on the survival of patients with breast cancer has been a subject of controversy for the recently decades. Many researchers assert that, in many of patients, breast cancer is a systemic illness from its starting and that node situation and local relapse are risk factors instead of the source of distant relapse (
3). Breast cancer is a heterogeneous illness with various clinical behaviors and treatment outcomes, notwithstanding similarities in characteristics, like the lymph node status, tumor size, and grade. This diversity can reflect the basic molecular biology of the illness. Molecular subtypes have been correlated with multiple recurrence rates and survival of patients with breast cancers. Generally, triple negative (TN) subgroup experience higher rates of local relapse and distant metastases, also lower survival rates. With the prognostic information obtained from molecular subtype analyses, there is refinement for personalized treatment for patients with breast cancer. Major component for treatment based on molecular subtype is the better conception of local and distant relapse in the presence of terminal event (
4). The effect of local and distant relapse on the outcome of patients with breast cancer has recently been a contention matter. Several authors assert that breast cancer is a systemic disease that node status and locoregional relapse are risk agents instead of the source of distant relapse. In many studies, adjuvant chemotherapy was related with decreased local and distant relapse rates and also with an increased relapse free survival rate, but not an increased whole survival rate. Various papers showed a high risk of experiencing a distant relapse after a local recurrence (
5). O’Shaughnessy showed a high link between a metastatic recurrence and death (
6). In several situations, recurrent events are as important measurements for determining progression of disease. According to statistical literature, non-informative censoring is commonly assumed when statistical methods are expanded or analyzing recurrent event data. In recurrent event data analysis, there are different models suggested in the matter of survival analysis, including conditional intensity models (
7-
9), marginal intensity models, the frailty model, and marginal means (
10,
11). In so many applications, although, there is a dependent terminal event like death that stops the follow-up. For instance, patients may experience repeated hospitalizations, which are terminated by death. For this special case, terminal event (death) should be accounted for here because it is probably be correlated with recurrent events. In recent decades, statistical analysis of recurrent event in the presence of terminal event has received much interest. For recurrent event data with a terminal event, both frailty and marginal methods are the commonly existing approaches, that for considering the relationship between the recurrent and terminal events, frailty models use random effects. For instance, some authors such as Huang for recurrent events and the terminal event proposed a frailty model with proportional intensity and proportional hazards, respectively (
12). Others provided a joint semi-parametric model, in which for considering the relation between the recurrent event data and terminal event, a shared gamma frailty hazard function is applied. (
13). Cook studied different classes of robust procedures for modeling the recurrent event mean in the presence of terminating event (
14).
In this paper, we consider two various kinds of recurrent events that can be correlated. In addition, death is assumed as a terminal event for the recurrence. Joint analyzing recurrent events with terminal event to making reliable inferences is essential. For joint-modeling of 3 correlated time-to-event responses, including locoregional relapse, distant relapse, and overall survival, a joint frailty hazard model is expanded.